- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 113.86M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $126M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $98.17M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $49.32M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $55.71M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $64.8M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $71.61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $252.88M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $296.47M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $283.8M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $327.9M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 94.8M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $70K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$52.53M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $422.33M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $257.8M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.49 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.49 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.7M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $52.71M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$58.35M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$62.4M |